TY  - CHAP
M1  - Book, Section
TI  - Schizophrenia
A1  - Crismon, M. Lynn
A1  - Kattura, Rania S.
A1  - Buckley, Peter F.
A2  - DiPiro, Joseph T.
A2  - Talbert, Robert L.
A2  - Yee, Gary C.
A2  - Matzke, Gary R.
A2  - Wells, Barbara G.
A2  - Posey, L. Michael
PY  - 2017
T2  - Pharmacotherapy: A Pathophysiologic Approach, 10e
AB  - Content  UpdateDecember  13,  2017Aripiprazole  Tablets  with  Sensor  (Abilify  MyCite)  for  Treatment  of  Adults  with  Schizophrenia:  Aripiprazole  tablets  with  sensor  (Abilify  MyCite)  is  a  drug-device  combination  product  comprised  of  tablets  embedded  with  an  Ingestible  Event  Marker  (IEM)  sensor  to  track  drug  ingestion.  The  product  is  indicated  for  treatment  of  schizophrenia,  bipolar  I  disorder,  and  adjunctive  treatment  in  adults  with  major  depressive  disorder.  Abilify  MyCite  has  not  been  established  to  improve  patient  adherence,  and  tracking  drug  ingestion  in  "real-time"  or  during  emergencies  is  not  recommended  because  detection  may  be  delayed  or  missed.  
SN  - 
PB  - McGraw-Hill Education
CY  - New York, NY
Y2  - 2024/04/18
UR  - accesspharmacy.mhmedical.com/content.aspx?aid=1149925821
ER  -